Andreas Hirt

4.4k total citations · 1 hit paper
89 papers, 3.1k citations indexed

About

Andreas Hirt is a scholar working on Hematology, Oncology and Immunology. According to data from OpenAlex, Andreas Hirt has authored 89 papers receiving a total of 3.1k indexed citations (citations by other indexed papers that have themselves been cited), including 37 papers in Hematology, 26 papers in Oncology and 24 papers in Immunology. Recurrent topics in Andreas Hirt's work include Acute Lymphoblastic Leukemia research (21 papers), Neutropenia and Cancer Infections (15 papers) and Hematopoietic Stem Cell Transplantation (13 papers). Andreas Hirt is often cited by papers focused on Acute Lymphoblastic Leukemia research (21 papers), Neutropenia and Cancer Infections (15 papers) and Hematopoietic Stem Cell Transplantation (13 papers). Andreas Hirt collaborates with scholars based in Switzerland, Germany and Canada. Andreas Hirt's co-authors include Hans Wägner, Paul Imbach, S Barandun, Christian Baumgärtner, A. Morell, M H Schöni, V. D’Apuzzo, M Vest, E. Rossi and Roland A. Ammann and has published in prestigious journals such as The Lancet, Journal of Clinical Oncology and Blood.

In The Last Decade

Andreas Hirt

88 papers receiving 2.9k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

HIGH-DOSE INTRAVENOUS GAMMAGLOBULIN FOR IDIOPATHIC THROMBOCYTOPENIC PURPURA IN CHILDHOOD

1981 1.2k citations Paul Imbach, Andreas Hirt et al. profile →

Peers

Countries citing papers authored by Andreas Hirt

Since Specialization

Citations

This map shows the geographic impact of Andreas Hirt's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andreas Hirt with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andreas Hirt more than expected).

Fields of papers citing papers by Andreas Hirt

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Andreas Hirt. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andreas Hirt. The network helps show where Andreas Hirt may publish in the future.

Co-authorship network of co-authors of Andreas Hirt

This figure shows the co-authorship network connecting the top 25 collaborators of Andreas Hirt. A scholar is included among the top collaborators of Andreas Hirt based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Andreas Hirt. Andreas Hirt is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Mannan-binding lectin (MBL) and MBL-associated serine protease-2 in children with cancer 2011 ·Swiss Medical Weekly ·Urs Fisch, Andreas Hirt, Arne Simon, (unknown), Felix Niggli, Luregn J. Schlapbach, (unknown)	16
2	Prognosis in pediatric hematologic malignancies is associated with serum concentration of mannose‐binding lectin‐associated serine protease‐2 (MASP‐2) 2009 ·Pediatric Blood & Cancer ·(unknown), Urs Fisch, Andreas Hirt, Felix Niggli, Arne Simon, (unknown), Luregn J. Schlapbach, Roland A. Ammann	21
3	Le Registre Suisse du Cancer de l'Enfant: premier registre du cancer national 2008 ·Bulletin des Médecins Suisses ·(unknown), Claudia E. Kuehni, Nicolas von der Weid, Maja Beck‐Popovic, Elisabeth Bruder, Ueli Caflisch, Jeanette Greiner, Jean‐Marc Joseph, Andreas Hirt, Felix Niggli, (unknown), (unknown), Michael Paulussen, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown)	0
4	Safety of ondansetron loading doses in children with cancer 2007 ·Supportive Care in Cancer ·(unknown), Andreas Hirt, (unknown), Kurt Leibundgut, Roland A. Ammann	9
5	Deficiency of Mannose-Binding Lectin-Associated Serine Protease-2 Associated With Increased Risk of Fever and Neutropenia in Pediatric Cancer Patients 2007 ·The Pediatric Infectious Disease Journal ·Luregn J. Schlapbach, Christoph Aebi, (unknown), Kurt Leibundgut, Andreas Hirt, Roland A. Ammann	36
6	In Childhood Acute Lymphoblastic Leukemia the Hypophosphorylated Retinoblastoma Protein, p110RB, Is Diminished, as Compared with Normal CD34+ Peripheral Blood Progenitor Cells 1999 ·Pediatric Research ·Kurt Leibundgut, (unknown), Andreas Tobler, A Lüthy, Andreas Hirt	6
7	Rechenmodell zum Aufprall von Kernschmelze auf die oberen Einbauten und den Deckel eines Reaktordruckbehälters 1998 ·Repository KITopen (Karlsruhe Institute of Technology) ·Andreas Hirt	1
8	Acute lymphoblastic leukaemia in childhood: cell proliferation without rest 1997 ·British Journal of Haematology ·Andreas Hirt, Vladan Antic, (unknown), (unknown), Kurt Leibundgut, Nicolas von der Weid, Andreas Tobler, Hans-Peter Wagner	8
9	High incidence of significant bone loss in patients with severe congenital neutropenia (Kostmann’s syndrome) 1997 ·The Journal of Pediatrics ·Elif Yakisan, E Schirg, Cornelia Zeidler, Nick Bishop, Alfred Reiter, Andreas Hirt, Hansjörg Riehm, Karl Welte	55
10	Tunneled, double lumen Broviac catheters are useful, efficient and safe in children undergoing peripheral blood progenitor cell harvesting and transplantation. 1996 ·PubMed ·Kurt Leibundgut, Chr. Müller, Karin Müller, (unknown), Andreas Hirt	14
11	Focal nodular hyperplasia of the liver in children: Review of follow-up and outcome 1995 ·Journal of Pediatric Surgery ·(unknown), J. Plaschkes, A Lüthy, Kurt Leibundgut, Andreas Hirt, Hans-Peter Wagner	53
12	Childhood NHL in Switzerland: Incidence and Survival of 120 Study and 42 Non‐Study Patients 1995 ·Medical and Pediatric Oncology ·Hans-Peter Wagner, (unknown), (unknown), A Lüthy, Andreas Hirt, (unknown), Daniel von der Beck, M Wyss, E Signer, Paul Imbach, A Feldges, (unknown), J. Plaschkes, J. Briner, Kurt Leibundgut, Nicolas von der Weid	46
13	Fetal haemoglobin levels in adult Type 1 (insulin-dependent) diabetic patients 1993 ·Diabetologia ·Peter Diem, Primus E. Mullis, Andreas Hirt, (unknown), (unknown), K Zuppinger, A Teuscher	13
14	CEREBROSPINAL FLUID INFLAMMATION INDUCED BY INTRAVENOUS IMMUNOGLOBULINS 1992 ·The Pediatric Infectious Disease Journal ·(unknown), (unknown), Andreas Hirt, Mario G. Bianchetti	14
15	Persisting Renotubular Sequelae after Cisplatin in Children and Adolescents 1991 ·American Journal of Nephrology ·(unknown), Christina Kanaka, (unknown), Andreas Hirt, Hans Wägner, O Oetliker	30
16	Repression of nuclear lamin A and C gene expression in human acute lymphoblastic leukemia and non-Hodgkin's lymphoma cells 1990 ·Leukemia Research ·(unknown), Edward W. Khandjian, Andreas Hirt, A Lüthy, Roger Weil, Hans Wägner	49
17	Inferior vena cava thrombosis in a child with nephroblastoma and combined deficiency of antithrombin III and free protein S 1990 ·Annals of Hematology ·(unknown), A Lüthy, Andreas Hirt, Miha Furlan, Bernhard Lämmle	3
18	Reactivity of Monoclonal Antibodies LAU-A1 and Anti-Y 29/55 in T and B Cell Malignancies of Children: Correlation with Immunological Markers and Clinical Data 1986 ·Acta Haematologica ·Andreas Hirt, S Carrel, (unknown), Christian Baumgärtner, Paul Imbach, E Signer, Hans-Peter Wagner	1
19	Haemophilia due to factor VIII inhibitors in a patient suffering from an autoimmune disease: Treatment with intravenous immunoglobulin 1984 ·Annals of Hematology ·Athos Gianella-Borradori, Andreas Hirt, (unknown), Hans Wägner, Paul Imbach	30
20	Intravenous immunoglobulin therapy: New aspects and outlook 1984 ·Annals of Hematology ·Paul Imbach, S Barandun, (unknown), Gerhard Gaedicke, Andreas Hirt, Hans Wägner	6

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact